These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32813942)

  • 21. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 22. Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Plotkin SA
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):517-518. PubMed ID: 32744616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unnecessary hesitancy on human vaccine tests-Response.
    Shah SK; Miller FG; Darton TC; Duenas D; Emerson C; Lynch HF; Jamrozik E; Jecker NS; Kamuya D; Kapulu M; Kimmelman J; MacKay D; Memoli MJ; Murphy SC; Palacios R; Richie TL; Roestenberg M; Saxena A; Saylor K; Selgelid MJ; Vaswani V; Rid A
    Science; 2020 Jul; 369(6500):151. PubMed ID: 32646992
    [No Abstract]   [Full Text] [Related]  

  • 24. Audio Interview: Covid-19 Vaccine Development.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(3):e40. PubMed ID: 32668131
    [No Abstract]   [Full Text] [Related]  

  • 25. Acceptance of a COVID-19 vaccine: A multifactorial consideration.
    García LY; Cerda AA
    Vaccine; 2020 Nov; 38(48):7587. PubMed ID: 33121656
    [No Abstract]   [Full Text] [Related]  

  • 26. Developing a SARS-CoV-2 Vaccine at Warp Speed.
    O'Callaghan KP; Blatz AM; Offit PA
    JAMA; 2020 Aug; 324(5):437-438. PubMed ID: 32628244
    [No Abstract]   [Full Text] [Related]  

  • 27. Covid-19 elimination: consider population level effects of vaccine.
    Payne N
    BMJ; 2020 Oct; 371():m3889. PubMed ID: 33023934
    [No Abstract]   [Full Text] [Related]  

  • 28. Russian SARS-CoV-2 vaccine.
    Caddy S
    BMJ; 2020 Aug; 370():m3270. PubMed ID: 32839191
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19 vaccine development pipeline gears up.
    Mullard A
    Lancet; 2020 Jun; 395(10239):1751-1752. PubMed ID: 32505245
    [No Abstract]   [Full Text] [Related]  

  • 30. An Inactivated Virus Candidate Vaccine to Prevent COVID-19.
    Mulligan MJ
    JAMA; 2020 Sep; 324(10):943-945. PubMed ID: 32789500
    [No Abstract]   [Full Text] [Related]  

  • 31. COVID-19 vaccines: Knowing the unknown.
    Lv H; Wu NC; Mok CKP
    Eur J Immunol; 2020 Jul; 50(7):939-943. PubMed ID: 32437587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice.
    Lu J; Lu G; Tan S; Xia J; Xiong H; Yu X; Qi Q; Yu X; Li L; Yu H; Xia N; Zhang T; Xu Y; Lin J
    Cell Res; 2020 Oct; 30(10):936-939. PubMed ID: 32801356
    [No Abstract]   [Full Text] [Related]  

  • 33. [Not Available].
    Red
    MMW Fortschr Med; 2020 Apr; 162(7):56. PubMed ID: 32291653
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 vaccine trials in Africa.
    Makoni M
    Lancet Respir Med; 2020 Nov; 8(11):e79-e80. PubMed ID: 32896275
    [No Abstract]   [Full Text] [Related]  

  • 35. Possible treatment of Covid-19 with a therapeutic vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Apr; 186(13):419. PubMed ID: 32245869
    [No Abstract]   [Full Text] [Related]  

  • 36. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 37. COVID-19: The race for a vaccine.
    Lockey E
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926902. PubMed ID: 32404020
    [No Abstract]   [Full Text] [Related]  

  • 38. Encouraging results from phase 1/2 COVID-19 vaccine trials.
    Bar-Zeev N; Moss WJ
    Lancet; 2020 Aug; 396(10249):448-449. PubMed ID: 32702300
    [No Abstract]   [Full Text] [Related]  

  • 39. The Russian vaccine for COVID-19.
    Burki TK
    Lancet Respir Med; 2020 Nov; 8(11):e85-e86. PubMed ID: 32896274
    [No Abstract]   [Full Text] [Related]  

  • 40. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
    Bull World Health Organ; 2020 Sep; 98(9):588-589. PubMed ID: 33012858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.